TianYu Bio-Technology Co., Ltd. (SHA:603717)
China · Delayed Price · Currency is CNY 7.64
-0.04 (-0.52%)
Feb 3, 2026, 3:00 PM CST
TianYu Bio-Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -115.36 | -107.36 | -461.64 | -279.41 | -214.74 | -157.45 |
Depreciation & Amortization | 64.45 | 64.45 | 64.65 | 43.7 | 18.12 | 13.71 |
Other Amortization | 1.25 | 1.25 | 0.99 | 0.73 | 0.9 | 3.52 |
Loss (Gain) From Sale of Assets | 0.67 | 0.67 | -0.99 | -47.44 | -8.81 | -0.13 |
Asset Writedown & Restructuring Costs | 7.93 | 7.93 | 14.97 | 58.57 | 1.8 | 32.49 |
Loss (Gain) From Sale of Investments | 0.21 | 0.21 | 109.7 | -1.84 | -17.47 | 4.9 |
Provision & Write-off of Bad Debts | 20.41 | 20.41 | 2.2 | 247.64 | 170.58 | 34.42 |
Other Operating Activities | 126.83 | 76.84 | 17.4 | 93.78 | 46.9 | 59.29 |
Change in Accounts Receivable | -56.56 | -56.56 | 29.49 | -290.33 | -84.1 | -124.42 |
Change in Inventory | 95.26 | 95.26 | 56.14 | 64.42 | -33.24 | 92.79 |
Change in Accounts Payable | 30.38 | 30.38 | 2.29 | 259.98 | -80.5 | -40.22 |
Change in Other Net Operating Assets | -1.35 | -1.35 | 0.56 | 1.36 | - | - |
Operating Cash Flow | 177.27 | 135.29 | -175.93 | 105.53 | -223.32 | -86.51 |
Capital Expenditures | -36.36 | -54.02 | -84.54 | -83.34 | -6.93 | -77.87 |
Sale of Property, Plant & Equipment | 0.22 | 0.53 | 0.03 | 220.09 | 21.63 | 1.85 |
Cash Acquisitions | -30.39 | -15.86 | -6.94 | -0.56 | 0 | - |
Divestitures | -0.99 | -0.99 | 2.4 | 0.16 | - | 16 |
Investment in Securities | - | -0.57 | 1.76 | -209.33 | 64.75 | -4.05 |
Other Investing Activities | -5.12 | 4.53 | -9.87 | 5.58 | - | 0 |
Investing Cash Flow | -71.14 | -64.89 | -102.24 | -93.63 | 79.45 | -64.07 |
Short-Term Debt Issued | - | - | - | 139.5 | 297.1 | 137.7 |
Long-Term Debt Issued | - | 486.88 | 629.11 | 884.28 | 568.05 | 526.41 |
Total Debt Issued | 368.81 | 486.88 | 629.11 | 1,024 | 865.15 | 664.11 |
Short-Term Debt Repaid | - | - | - | -189.5 | -272.3 | -112.5 |
Long-Term Debt Repaid | - | -492.61 | -438.57 | -798.36 | -807.14 | -469.08 |
Total Debt Repaid | -445.68 | -492.61 | -438.57 | -987.86 | -1,079 | -581.58 |
Net Debt Issued (Repaid) | -76.87 | -5.73 | 190.53 | 35.91 | -214.29 | 82.53 |
Issuance of Common Stock | - | - | 0.71 | - | 396.57 | - |
Common Dividends Paid | -50.33 | -43.31 | -43.81 | -56.32 | -50.08 | -60.21 |
Other Financing Activities | -15.53 | -16.22 | -15.78 | 73.71 | 73.71 | 23.48 |
Financing Cash Flow | -142.72 | -65.26 | 131.66 | 53.3 | 205.92 | 45.8 |
Foreign Exchange Rate Adjustments | 0.11 | 0.09 | - | - | - | - |
Net Cash Flow | -36.48 | 5.23 | -146.51 | 65.2 | 62.05 | -104.78 |
Free Cash Flow | 140.91 | 81.27 | -260.48 | 22.19 | -230.25 | -164.38 |
Free Cash Flow Margin | 19.77% | 10.14% | -38.85% | 2.35% | -36.09% | -28.22% |
Free Cash Flow Per Share | 0.49 | 0.28 | -0.90 | 0.09 | -0.87 | -0.68 |
Cash Income Tax Paid | 14.55 | 14.15 | 10.44 | 28.76 | 33.96 | 16.92 |
Levered Free Cash Flow | 25.32 | 241.07 | -96.83 | 81.23 | -304.4 | -67.4 |
Unlevered Free Cash Flow | 59.83 | 263.9 | -77.73 | 99.47 | -273.93 | -31.14 |
Change in Working Capital | 70.89 | 70.89 | 76.79 | -10.19 | -220.59 | -77.26 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.